
Jeffrey T. Palenik
Examiner (ID: 10079, Phone: (571)270-1966 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 1154 |
| Issued Applications | 622 |
| Pending Applications | 123 |
| Abandoned Applications | 453 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10837553
[patent_doc_number] => 08865225
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-21
[patent_title] => 'Composition comprising a solid state hypothiocyanite salt of a cation'
[patent_app_type] => utility
[patent_app_number] => 13/648365
[patent_app_country] => US
[patent_app_date] => 2012-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3735
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13648365
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/648365 | Composition comprising a solid state hypothiocyanite salt of a cation | Oct 9, 2012 | Issued |
Array
(
[id] => 9719682
[patent_doc_number] => 20140255382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'SOLID COMPOSITION CONTAINING A HYPOTHIOCYANITE SALT'
[patent_app_type] => utility
[patent_app_number] => 14/350446
[patent_app_country] => US
[patent_app_date] => 2012-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6461
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350446
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/350446 | Solid composition containing a hypothiocyanite salt | Oct 9, 2012 | Issued |
Array
(
[id] => 8767156
[patent_doc_number] => 20130095194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'USE OF INHALED NITROUS OXIDE OR XENON FOR PREVENTING NEUROPATHIC PAIN CAUSED BY CANCER CHEMOTHERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/647495
[patent_app_country] => US
[patent_app_date] => 2012-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3146
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13647495
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/647495 | USE OF INHALED NITROUS OXIDE OR XENON FOR PREVENTING NEUROPATHIC PAIN CAUSED BY CANCER CHEMOTHERAPY | Oct 8, 2012 | Abandoned |
Array
(
[id] => 10593366
[patent_doc_number] => 09314436
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-19
[patent_title] => 'Manufacturing method of patch preparation'
[patent_app_type] => utility
[patent_app_number] => 13/630945
[patent_app_country] => US
[patent_app_date] => 2012-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 10931
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13630945
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/630945 | Manufacturing method of patch preparation | Sep 27, 2012 | Abandoned |
Array
(
[id] => 8617324
[patent_doc_number] => 20130022636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-24
[patent_title] => 'Physical Mode of Action Pesticide'
[patent_app_type] => utility
[patent_app_number] => 13/628625
[patent_app_country] => US
[patent_app_date] => 2012-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4697
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13628625
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/628625 | Physical mode of action pesticide | Sep 26, 2012 | Issued |
Array
(
[id] => 11210853
[patent_doc_number] => 09439871
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-13
[patent_title] => 'Method for preparing nano particles'
[patent_app_type] => utility
[patent_app_number] => 14/344256
[patent_app_country] => US
[patent_app_date] => 2012-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5198
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14344256
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/344256 | Method for preparing nano particles | Sep 20, 2012 | Issued |
Array
(
[id] => 8612691
[patent_doc_number] => 20130018003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-17
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING AIDS OR CANCER BY INHIBITING THE SECRETION OF MICROPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 13/621597
[patent_app_country] => US
[patent_app_date] => 2012-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 10731
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13621597
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/621597 | Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles | Sep 16, 2012 | Issued |
Array
(
[id] => 8612690
[patent_doc_number] => 20130018002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-17
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING AIDS OR CANCER BY INHIBITING THE SECRETION OF MICROPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 13/621618
[patent_app_country] => US
[patent_app_date] => 2012-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 10746
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13621618
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/621618 | Compositions and methods for treating cancer by inhibiting the secretion of microparticles | Sep 16, 2012 | Issued |
Array
(
[id] => 8567279
[patent_doc_number] => 20120329850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-27
[patent_title] => 'Methods for treating retinopathy with extended therapeutic effect'
[patent_app_type] => utility
[patent_app_number] => 13/604809
[patent_app_country] => US
[patent_app_date] => 2012-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 22714
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13604809
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/604809 | Methods for treating retinopathy with extended therapeutic effect | Sep 5, 2012 | Abandoned |
Array
(
[id] => 8649648
[patent_doc_number] => 20130035378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-07
[patent_title] => 'FILM DELIVERY SYSTEM FOR TETRAHYDROLIPSTATIN'
[patent_app_type] => utility
[patent_app_number] => 13/588267
[patent_app_country] => US
[patent_app_date] => 2012-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14441
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13588267
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/588267 | Film delivery system for tetrahydrolipstatin | Aug 16, 2012 | Issued |
Array
(
[id] => 10044381
[patent_doc_number] => 09084764
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-21
[patent_title] => 'Epidermal cooling'
[patent_app_type] => utility
[patent_app_number] => 13/587445
[patent_app_country] => US
[patent_app_date] => 2012-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5243
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13587445
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/587445 | Epidermal cooling | Aug 15, 2012 | Issued |
Array
(
[id] => 8853197
[patent_doc_number] => 20130142872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => 'EMP2: Ethyl-Methyl, di Methyl, tri Methyl Pyruvate Acid Esters: A Tool for Regulating HbA1c and a Riboswitch Activator'
[patent_app_type] => utility
[patent_app_number] => 13/570454
[patent_app_country] => US
[patent_app_date] => 2012-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10048
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13570454
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/570454 | EMP2: Ethyl-Methyl, di Methyl, tri Methyl Pyruvate Acid Esters: A Tool for Regulating HbA1c and a Riboswitch Activator | Aug 8, 2012 | Abandoned |
Array
(
[id] => 8495499
[patent_doc_number] => 20120294907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => 'TWO OR MORE SOLIDIFYING AGENT-CONTAINING COMPOSITIONS AND METHODS FOR DERMAL DELIVERY OF DRUGS'
[patent_app_type] => utility
[patent_app_number] => 13/567289
[patent_app_country] => US
[patent_app_date] => 2012-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17353
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13567289
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/567289 | TWO OR MORE SOLIDIFYING AGENT-CONTAINING COMPOSITIONS AND METHODS FOR DERMAL DELIVERY OF DRUGS | Aug 5, 2012 | Abandoned |
Array
(
[id] => 11210855
[patent_doc_number] => 09439873
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-13
[patent_title] => 'Application aid'
[patent_app_type] => utility
[patent_app_number] => 14/236415
[patent_app_country] => US
[patent_app_date] => 2012-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 5082
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14236415
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/236415 | Application aid | Aug 2, 2012 | Issued |
Array
(
[id] => 9642035
[patent_doc_number] => 20140220147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING FACTOR VII ENCAPSULATED IN MICELLES'
[patent_app_type] => utility
[patent_app_number] => 14/236150
[patent_app_country] => US
[patent_app_date] => 2012-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13077
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14236150
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/236150 | PHARMACEUTICAL COMPOSITION COMPRISING FACTOR VII ENCAPSULATED IN MICELLES | Jul 30, 2012 | Abandoned |
Array
(
[id] => 9881635
[patent_doc_number] => 08968392
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-03
[patent_title] => 'Method of inhibiting vascular intimal hyperplasia using stent'
[patent_app_type] => utility
[patent_app_number] => 13/561828
[patent_app_country] => US
[patent_app_date] => 2012-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 13591
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13561828
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/561828 | Method of inhibiting vascular intimal hyperplasia using stent | Jul 29, 2012 | Issued |
Array
(
[id] => 9354807
[patent_doc_number] => 08673338
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-18
[patent_title] => 'Methods of delivering pharmaceutical agents'
[patent_app_type] => utility
[patent_app_number] => 13/561998
[patent_app_country] => US
[patent_app_date] => 2012-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 24
[patent_no_of_words] => 23739
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13561998
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/561998 | Methods of delivering pharmaceutical agents | Jul 29, 2012 | Issued |
Array
(
[id] => 9843686
[patent_doc_number] => 08945597
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-03
[patent_title] => 'Botanical insecticides'
[patent_app_type] => utility
[patent_app_number] => 13/526455
[patent_app_country] => US
[patent_app_date] => 2012-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4391
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13526455
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/526455 | Botanical insecticides | Jun 17, 2012 | Issued |
Array
(
[id] => 9634264
[patent_doc_number] => 20140212373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-31
[patent_title] => 'Multi-Vinylsulfone Containing Molecule'
[patent_app_type] => utility
[patent_app_number] => 14/126725
[patent_app_country] => US
[patent_app_date] => 2012-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8569
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14126725
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/126725 | Multi-vinylsulfone containing molecule | Jun 14, 2012 | Issued |
Array
(
[id] => 9654028
[patent_doc_number] => 20140225033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'DIALYSIS PRECURSOR COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 14/128375
[patent_app_country] => US
[patent_app_date] => 2012-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3883
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14128375
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/128375 | Dialysis precursor composition | Jun 10, 2012 | Issued |